Understanding Retinal artery occlusion: central and branch
Central retinal artery occlusion can cause severe monocular loss; a branch occlusion affects the territory of a smaller artery. Some small branch events cause little noticed change. The location of damage and any preserved central supply influence function, so a single image cannot represent every event. [2]
Retinal arterial ischemia is also a systemic vascular warning. Clinicians look for a source such as carotid or cardiac disease and consider inflammatory causes where appropriate. Emergency evaluation matters even when no reliably restorative eye treatment is available. [1]
One condition. Different experiences.
Experiences can vary with the cause, task and person. These descriptions are examples, not a checklist for self-diagnosis.
An abrupt missing area
People may report a sudden dark, grey or absent area in one eye. The other eye can conceal a monocular deficit during ordinary binocular viewing. A normal-looking external eye does not exclude retinal ischemia. [2]
Central versus sector loss
CRAO often affects a large area and fine detail; BRAO may produce a more localized field defect. A person retaining reading acuity can still have an important field deficit. [2]
Blur or altered shape
Some people notice blur, blind spots or distortion rather than complete darkness. Symptoms alone cannot separate artery occlusion from other urgent retinal or neurological causes. [3]
What is happening—and what remains uncertain
An embolus, local clot or another arterial process can obstruct retinal perfusion. Arteritic disease, including giant cell arteritis, requires a different systemic treatment approach from most nonarteritic occlusions. Clinicians establish the mechanism rather than treating every event as the same kind of clot. [1]
The retina is neural tissue, so interrupted oxygen delivery can cause lasting injury. A transient retinal ischemic episode and an established infarction are related vascular presentations but do not have identical tissue outcomes. Restored circulation does not guarantee restored visual function. [4]
What can look similar?
Retinal vein occlusion
A vein drains blood rather than delivering arterial oxygen. Its blockage can cause bleeding and macular swelling; treatments and immediate systemic priorities differ. Sudden loss still deserves prompt assessment. [3]
Ocular ischemic syndrome
Chronic reduced inflow from carotid disease can affect multiple eye tissues. OIS is not simply another name for a central retinal artery blockage, although vascular causes can overlap. [1]
Giant cell arteritis
In an older person, headache, jaw symptoms or systemic features may prompt urgent investigation for arteritis. Absence of a classic symptom checklist does not let a simulator rule it out. [1]
Similar-looking symptoms can have different causes. A matching picture cannot establish a diagnosis.
What an assessment may involve
- Establish the eye diagnosisA dilated examination, pupils, acuity and retinal imaging such as OCT help identify the involved vessel and tissue changes. Angiography or field testing may add information according to the situation. [3]
- Use an emergency stroke pathwayThe team evaluates brain and vascular circulation and possible cardiac sources. An isolated eye symptom can coexist with clinically silent brain ischemia; examination outside the eye matters. [1]
- Assess the cause and baselineHistory includes onset, prior transient episodes, vascular conditions and relevant procedures or exposures. Inflammatory testing is targeted to the clinical context. Measurements also establish a baseline for later rehabilitation and complication monitoring. [1] [4]
What may help—and what is still being studied
Discuss acute options honestly
Specialist emergency teams assess potential interventions, timing, contraindications and local protocols. Recent randomized trials did not establish a routine visual benefit from intravenous alteplase or tenecteplase, and the tenecteplase trial raised serious safety concerns. This is not a reason to delay emergency assessment. [5] [6]
Prevent another vascular event
Clinicians address the identified embolic source and vascular prevention. Treatment is individualized; comparing thrombolysis with aspirin in a trial is not an instruction to take aspirin at home or to stop prescribed medicines. [1]
What this can mean for daily life
Find a workable reading method
Use larger text, magnification, contrast adjustment or speech output. An individual assessment can identify whether reading difficulty comes from central detail loss, field loss or both. [7]
Support safe navigation
Ask about orientation and mobility training, stairs and scanning strategies. Someone with good chart acuity may still need help noticing obstacles in a missing sector. [7]
Review transport and work
Discuss driving rules and a functional assessment locally. Workplace adjustments can include accessible documents, screen tools and flexible methods rather than relying only on a diagnosis label. [7]
Bring a clearer description to your appointment
Choose the questions you want to discuss. These choices stay in this page’s memory.
Research, with the context left in
Selected studies and guidance, with their populations and limitations. These are curated educational summaries, not a complete systematic review or a formal evidence rating.
AAO Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern
Recommends immediate stroke-center emergency referral for acute symptomatic arterial occlusion and targeted systemic investigation. [1]
Limits and applicability: Published before the final TenCRAOS results. Older discussion of acute therapies must be interpreted alongside newer randomized evidence.
THEIA: intravenous alteplase versus aspirin
The primary visual-improvement comparison was not statistically significant, despite numerically more improvement with alteplase. One asymptomatic intracranial hemorrhage was reported in that arm. [5]
Limits and applicability: Small sample, missing primary outcomes and wide uncertainty; a negative result does not establish equivalence or zero bleeding risk. Results concern selected CRAO, not all branch or arteritic events.
TenCRAOS: tenecteplase versus aspirin
At 30 days, recovery to at least 20/100 occurred in 20% versus 24%; no significant visual advantage was found. Tenecteplase had more adverse events, including a fatal intracranial hemorrhage. [6]
Limits and applicability: Modest sample and wide confidence interval do not support a universal benefit or a precise individual risk estimate. These results do not remove the need for emergency stroke evaluation.
Questions researchers still need to answer
- Can an acute intervention improve patient-important vision with an acceptable safety profile in a clearly defined CRAO subgroup?
- Which rehabilitation strategies best support reading and mobility after differing retinal field injuries?
Trusted places to go next
Selected clinical references, research, practical support and ways to connect. Official pages checked 24 October 2026; each entry explains its scope and region.
American Society of Retina Specialists patient guide
Accessible explanation of central and branch arterial occlusion and retinal examination; not an emergency contact service.
NANOS specialist directory
Search neuro-ophthalmology professionals. Listing does not guarantee an appointment, insurance coverage or emergency access.
National Eye Institute low-vision resources
Information on vision rehabilitation, accessible devices and task adaptations; ask locally about referral and service availability.
American Stroke Association
Stroke education and adjustment support for people and families affected by stroke. Groups are broader than retinal arterial disease; check local eligibility and schedules.
Connections listed by the organization.
Questions you may still have
Is painless loss less urgent?
No. Sudden painless monocular loss is a typical presentation of retinal arterial ischemia and requires immediate assessment. [2]
Does a branch event matter if I can still read?
Yes. It may spare central acuity while affecting another part of the field, and still calls for evaluation of the underlying systemic cause. [1] [2]
Sources, image credits and review status
Compiled by VisualSim from clinical references and published research. Sources checked 24 October 2026. Independent clinical review has not been recorded; no named clinical reviewer or clinical validation is claimed. Research evidence and its limitations are linked below.
- AAO — Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern (2025; guideline).
Original publisher indexed definition, examination and management sections checked; direct reader returned 403. Published February 7, 2025.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - ASRS — Central Retinal Artery Occlusion (n.d.; institution).
Public source checked for the stated scope; source checking is not clinical review.
Checked 2026-10-24 · Public page checked - AAO — What Is a Retinal Artery Occlusion? (2026; institution).
Original indexed January 15, 2026 patient page checked. Historical massage and other unproven methods are not promoted or translated into home instructions.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - AHA — Management of Central Retinal Artery Occlusion (2021; guideline).
Official scientific statement hub checked; its earlier acute-treatment uncertainty is updated here with 2025–2026 trials.
Checked 2026-10-24 · Public page checked - THEIA — Intravenous alteplase versus oral aspirin for acute central retinal artery occlusion (2025; trial).
Original publisher indexed abstract read, including missing outcomes and nonsignificant primary comparison. Direct reader returned 403.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - Ryan et al. — A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion (2026; trial).
Original publisher indexed current abstract read; published January 28 and updated August 6, 2026. Current randomization/exclusion counts retained; no full-text access claimed.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - National Eye Institute — Low Vision (2025; institution).
Public source checked for the stated scope; source checking is not clinical review.
Checked 2026-10-24 · Public page checked
The simulator helps people communicate an experience. It cannot diagnose a condition, measure a visual field, or establish that someone is safe to drive.